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RESEARCH ARTICLE

Open Access

Multi-TGDR, a multi-class regularization method,
identifies the metabolic profiles of hepatocellular
carcinoma and cirrhosis infected with hepatitis B
or hepatitis C virus
Suyan Tian1*, Howard H Chang3, Chi Wang4, Jing Jiang1, Xiaomei Wang2 and Junqi Niu2*

Abstract
Background: Over the last decade, metabolomics has evolved into a mainstream enterprise utilized by many
laboratories globally. Like other “omics” data, metabolomics data has the characteristics of a smaller sample size
compared to the number of features evaluated. Thus the selection of an optimal subset of features with a
supervised classifier is imperative. We extended an existing feature selection algorithm, threshold gradient descent
regularization (TGDR), to handle multi-class classification of “omics” data, and proposed two such extensions referred
to as multi-TGDR. Both multi-TGDR frameworks were used to analyze a metabolomics dataset that compares the
metabolic profiles of hepatocellular carcinoma (HCC) infected with hepatitis B (HBV) or C virus (HCV) with that of
cirrhosis induced by HBV/HCV infection; the goal was to improve early-stage diagnosis of HCC.
Results: We applied two multi-TGDR frameworks to the HCC metabolomics data that determined TGDR thresholds
either globally across classes, or locally for each class. Multi-TGDR global model selected 45 metabolites with a 0%
misclassification rate (the error rate on the training data) and had a 3.82% 5-fold cross-validation (CV-5) predictive
error rate. Multi-TGDR local selected 48 metabolites with a 0% misclassification rate and a 5.34% CV-5 error rate.
Conclusions: One important advantage of multi-TGDR local is that it allows inference for determining which feature
is related specifically to the class/classes. Thus, we recommend multi-TGDR local be used because it has similar
predictive performance and requires the same computing time as multi-TGDR global, but may provide class-specific
inference.
Keywords: Threshold gradient descent regularization (TGDR), Multi-class classification, Metabolic profile,
Hepatocellular carcinoma (HCC), Feature selection, Metabolomics, Omics data

Background
Feature selection algorithms, which select a subset of
the most relevant features for the underlying data mining tasks, are commonly used in combination with classifier construction to analyze “omics” data or data with
high-dimensional input variables. The benefits of feature
selection include minimizing model over-fitting, improved
predictive performance, and computational efficiency. It
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may also provide insights on potential targets that relate
to the fundamental differences among different classes or
subtypes of a biological process [1]. Threshold Gradient
Descent Regularization (TGDR) [2], one such algorithms,
has been explored and implemented by us [3-5] extensively because it possesses several key advantages, as described in our previous paper [4].
Currently, multi-class classification, where an observation needs to be categorized into more than two classes,
has attracted increasing attention in the statistics and
bioinformatics literatures [6-10]. Its popularity may be
attributed to the fact that multi-class classification is
commonly encountered in real-world applications. For
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example, multiple classes can represent different tumor
types or different responses to a therapy. According to
Li et al. [6], multi-class classification can be roughly divided into two types. One type includes classification
algorithms that can be directly extended to handle multiclass cases, and the other type includes algorithms that
arise from the decomposition of multi-class problems into
a series of binary ones.
While a series of binary TGDRs can be easily constructed to accomplish multi-class classification, it is more
desirable to extend TGDR directly to the multi-class cases
since this approach results in a substantial decrease of the
number of classifiers being trained. The major technical
difficulty associated with such extension of TGDR involves defining an overall threshold for a feature across
different classes, which is not addressed in the original
TGDR framework [2,11]. In our previous work [4], we introduced one approach, referred to as multi-TGDR, for
determining the threshold function. We applied the proposed multi-TGDR framework to two real-world data
conducted on the Affymetrix HG-U133 Plus 2 platform
and demonstrated that multi-TGDR was superior in terms
of predictive accuracy and parsimony compared to its binary counterparts (i.e., one-versus-another schema). In this
paper, we propose a more general method to determine
the threshold function, which allows the threshold function to be class-specific.
Metabolomics is the “…systematic study of the unique
chemical fingerprints that specific cellular processes leave
behind” [12]. Over the last decade, metabolomics has
evolved into a mainstream scientific approach practiced
by many laboratories globally. The information conveyed
in metabolomics data can provide insight for a variety of
applications such as biomarker identification, clinical toxicology, and drug discovery and development [13]. Like
other “omics” data, metabolomics data typically has the
characteristics of a smaller sample size compared to the
number of features (usually hundreds of metabolites after
peak alignment). Therefore, it is crucial to implement
feature selection. However, metabolomics data analysis is
less standardized compared to other “omics” data analysis
(e.g., microarray and Next-Generation Sequencing [NGS])
due to its complexity. Consequently, many of the existing
feature selection algorithms have not been explored and
implemented in metabolomics data analyses. Only a few
algorithms have been proposed to specifically analyze
mass spectrometry (MS) data [14]. Reviews on feature selection algorithms that may be used in metabolomics data
analyses have been reported [1,15].
Partial Least Square-Discrimination Analysis (PLS-DA)
is a very popular multivariate analysis tool, which is commonly used in metabolomics data analyses to identify informative metabolites for many distinct purposes, such as
the diagnosis or prognosis of a disease [16-19]. Notably,
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the success of the stand-alone software SIMCAP (www.
umetrics.com) boosts the prevalence applications of PLSDA in metabolomics data analyses. As a supervised
method, PLS-DA rotates the Principal Component Analysis (PCA) components by using the class membership
information to achieve a better separation between the
classes of samples. Similar to PCA, the results from
PLS-DA are based on some linear combinations of all
metabolites or at least the linear combinations of the selected metabolites by naively leaving out the metabolites
with small variable influence on the projection (VIP, which
is a weighted sum of PLS loadings). This approach not only
lacks readily biological interpretation, but also does not
provide valid statistics that can be used to evaluate its predictive performance. To obtain such statistics, an extra classifier is desirable in PLS-DA. For example, the study by
Student and Fujarewicz [10] obtained the accuracy of PLSDA by implementing an additional support vector machine
(SVM) classifier. Furthermore, absence of predictive rules
in PLS-DA makes the results of PLS-DA less practical. This
is because in clinical practice, physicians would prefer to a
score (e.g., posterior probabilities) to quantify a patient’s
status. Therefore, an explicit predictive rule is essential for
metabolomics to become a diagnostic tool.
In this paper, we investigate the use of two multi-TGDR
approaches to analyze mass spectrometry metabolomics
data. Hepatocellular carcinoma (HCC) is the most common
type of liver cancer. Most cases of HCC are secondary to either a viral hepatitis (hepatitis B or C) or cirrhosis [20].
Currently, the gold standards for diagnosis (e.g., ultrasonography and alpha-fetoprotein [AFP]) have been reported to
lack satisfactory sensitivity and specificity for identifying
HCC at early stages [21,22]. Since metabolomics can monitor the changes in small molecular comprehensively and
provide insight on metabolic deregulations systematically
[23,24], researchers are employing metabolomics techniques to elucidate the difference between HCC and cirrhosis [19]. The identification of metabolic profiles for HCC/
cirrhosis infected with HBV or HVC may help discriminate
between HCC/cirrhosis/normal classes and achieve accurate diagnosis of HCC at early stages. Moreover, the analyses presented in this paper also provide motivation for
developing feature selection algorithms specifically for
metabolomics data, and for the applications of existing
algorithms to metabolomics data.

Methods
The experimental data

The study included 30 patients with cirrhotic liver disease
(22 infected with HBV and 8 with HCV, respectively), 70
patient with HCC (39 with HBV infection and 31 with
HCV infection), and 31 healthy volunteers recruited in the
metabolic profiling study. All of them provided the written
informed consent, and the ethics committee of the Jilin
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University approved upon this study. Detailed descriptions
on the study design, experimental procedures, and LC-MS
metabolomics data collections were reported in [19].
Pre-processing procedures

Raw data were imported into Databridge (Waters, U.K.) for
data format transformation. The resulting NeTCDF files
were imported into XCMS software for the peak extraction
and alignment. Then the peaks including 384 metabolites
(indexed by the combination of m/z and retention time,
and their corresponding peak intensities) and 131 samples
were exported to an Excel file. The peak intensity values
were log transformed so that the distribution of the transformed intensity values for each metabolite was approximately normal. Zeros (corresponding to no peaks) in peak
intensity, were replaced by a nominal value (i.e., 0.01) before log transformation, to avoid the creation of missing
values. Several other values for replacing zero values (i.e.,
0.001, 0.005, 0.02, 0.05) were examined to evaluate if different nominal values would affect the results, and no difference was found. Finally, peak intensity values were further
centralized and normalized to have a mean of 0 and a variance of 1. The resulting matrix was used in the two multiTGDR frameworks for the classification analysis.
Compounds identification was achieved by comparing
the accurate mass of compounds from the Human Metabolome Database: HMDB version 3 (www.hmdb.ca).
Methods

Here, we omit the description of binary TGDR. Interested readers may refer to the original papers [2,11] for
the detailed descriptions on binary TGDR. We present
two multi-class TGDR frameworks with emphasis on the
specific modifications made on the overall threshold
functions to handle the multi-class problem.

In the multi-class cases, we have a set of C-1 binary variables Yci , which are the indicators for class c on subject i
(i = 1,…,n, here n is the total number of subjects) i.e., Yci is
equal 1 if the ith subject belongs to class c and zero otherwise. C is the number of classes (C ≥ 3) and X1,…,Xn represents the feature values of one specific subject. Notably, Xi
is a vector of length G and thus X is an n×G matrix with
Xij for the corresponding intensity values of feature j (j =
1,…,G) on subject i. The log-likelihood function is defined as,

n
C−1
X
X
i¼1

c¼1



Y ci βc0 þ βc X i T − log

1þ

C−1
X
c¼1



exp βc0 þ βc X i

Method 1

Denote Δv as the small positive increment (e.g., 0.01) in
ordinary gradient descent search and vk = k×Δv as the
index for the point along the parameter path after k
steps. Let β(vk) denote the parameter estimate of β corresponding to vk. For a fixed threshold 0 ≤τ≤ 1, our proposed TGDR algorithm for multi-class cases is given as
follows:
1. Initialize β(0)=0 and v0=0.
2. With current estimate β, compute the negative
gradient matrix g(v) = − ∂R(β)/∂β with its (c,j)th
component as gcj(v).
3. a) Let fc(v) represent the threshold vector of size G
for class c (c=1,..,C-1), with its jth component
calculated as
!




f ðvÞ ¼ I jg ðvÞj≥τ  max g ðvÞ
∀j∈β
cj

cj

cl
l∈βc

c

b) Then, the jth-feature specific threshold function
was defined as
 
f j ðvÞ ¼ max f cj
c

Extension to multi-class classification

RðβÞ ¼

βc0s (c = 1,…,C-1) are unknown intercepts which are
not subject to regularization. βc = (βc1,…, βcG) are the
corresponding coefficients for the expression values of
metabolites under consideration. In an ‘omics’ experiment, most of those betas are assumed to be zeros, implying the corresponding features are non-informative in
explaining the difference across different classes. In the
multi-class cases, the threshold functions of every feature (i.e., metabolites in our application) in TGDR need
to be redefined across classes. In previous work [4], we
proposed an extension of TGDR as described below.


T

ð1Þ
!!

4. Update β(v+Δv) = β(v) - Δv×g(v)×f(v) and update v
by v+Δv , where the (c, j)th component of the product of f and g is gcj(v) × fj(v).
5. Steps 2-4 are iterated K times. The number of iteration K is determined by cross validation.
As in binary TGDR, all metabolites are assumed to be
non-informative at the initial stage. Parameters τ and k
are the tuning parameters, and thus jointly determine
the property of the estimated coefficients, including the
selection of features and their corresponding magnitudes. τ can be regarded as a threshold because it determines how βs would be updated in each iteration. Two
extreme cases include: if τ=0, all coefficients are nonzero
for all values of k; and if τ=1, the multi-TGDR increases
in the direction of one (if the gradient of the intercept
term has the largest absolute value) or two covariates in
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each iteration. Consequently, the non-zero coefficients
are few at the early iterations. With increasing k, increasing number of βs would deviate from zeros until all
of them would eventually enter the model. Both τ and K
are determined by using cross-validations [25].
In this framework, when one feature is selected in one
comparison, it will appear in the rest comparisons even
though it may not be informative in those comparisons.
This is analogous to the multivariate regression model
setting, where the same set of covariates is used for each
response even though some of them may not be statistically significant. Alternatively, we may choose to force
small estimated coefficients into zeros in the last step.
Then, the set of selected features for each comparison
becomes different. This framework is referred to as
multi-TGDR global herein.
On the other hand, one may argue why not set fj as
the minimum of fcjs instead of their maximum. So if,
there is no update until one feature has large enough
gradients for all C-1 comparison. Therefore, only features which are informative in all comparisons will be
chosen, resulting in an optimal feature set that is used
to classify all classes simultaneously. This is in conflict
with the hypothesis that a good feature set consists of
those highly correlated with a class but uncorrelated
with other classes, which had been confirmed by Hall
[26]. Moreover, the performance of such determination
has been proved to be generally less favorable than that
of one-versus-another or one-versus-the rest binary
ensembles [10].
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Method 2

Instead of having an overall threshold function for jth
feature, a cth-class specific threshold function for the feature is used to select features. This modification corresponds to the step 3a in the multi-TGDR global
framework. Thus, a feature is not necessarily selected in
other comparisons when it is updated in one comparison. As a result, different sets of selected features are associated with different classes. This framework is herein
referred to as multi-TGDR local. Figure 1 shows the
flowcharts of multi-TGDR global and multi-TGDR local,
and pinpoints the difference between two frameworks.
In the above two frameworks, we treat τ as a uniform
tuning parameter across classes, which can certainly be
relaxed so that τ may take different values for each class,
allowing different degrees of regularization for different
comparisons. However, for the “omics” data where the
number of features is much larger than the number of
samples, in our experience τ=1 tends to give the most
reasonable results. Firstly, it has the harshest threshold,
resulting in the smallest set of selected features. Secondly, the predictive performance may be improved by
discarding those non-informative or redundant features.
Bagging and brier score

Bagging [27] procedure was used to discard the possible noise from a single run of multi-TGDR, so that a
better model parsimony can be warranted. The benefits
of bagging include but are not limited to: avoidance of
over-fitting, improvement on prediction, and manageable

Figure 1 The flowchart of multi-TGDR. Global: multi-TGDR global; local: multi-TGDR local.
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experimental verification. In many applications, e.g., [10],
bootstrap resampling/bagging is mainly used to evaluate
the stability of a classifier.
Besides the traditionally used confusion matrix and
misclassification rate, the generalized brier score (GBS)
[7] was also calculated to evaluate the predictive performance of two multi-TGDR frameworks by absorbing
the extra information provided by the estimated posterior probabilities. Additional details on trimming performed on both bagging and brier score for multi-class
classifications were discussed in a previous study [4].
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that of PLS-DA. Even after bagging, the final models for
both multi-TGDRs include substantially more features
than the true ones, which might indicate more improvement in the multi-TGDR frameworks and other relevant
algorithms may exist.
Real data

The statistical analysis was carried out in the R language
version 2.15 (www.r-project.org), R codes for multiTGDR are available upon request.

A metabolomics study was conducted with the objectives
of identifying potentially important differential metabolites
related to HCC pathogenesis and early diagnosis, and thus
providing an explicit predictive rule that can aid a physician’s diagnosis on HCC and cirrhosis. There were 131
subjects (70 with HCC, 30 with cirrhosis, and 31 normal
controls, respectively) and 384 metabolites in this study.
Additional details on this motivating study have been presented in [19]. Figure 2 outlines the schema of this study.

Results and discussion

Performance of multi-TGDR

Synthesized data

In Figure 3, cross-validation scores showed minimal
change, especially after k > 500 for both frameworks. So
the final iteration number K in both Multi-TGDR global
and Multi-TGDR local was chosen as 500. Table 2 presents the results of the two multi-TGDR approaches.
Multi-TGDR global selected 45 metabolites with a 0%
misclassification rate and a 3.82% 5-fold cross-validation
predictive error rate. With the cutoff of bagging frequency
fixed at 40%, 30 metabolites were retained in the final
model (Model 1_w), which had a 0% misclassification rate
and a slight improvement on GBS. On the other hand,
Multi-TGDR local selected 48 metabolites with a 0% misclassification rate and a 5.34% CV-5 error rate. After applying Bagging, 29 were identified in the final model
(Model 2_w) with a slight decrement in GBS. Interestingly, the metabolites in model 1_w and model 2_w are almost the same (25 overlapped). Model 1_w identified 5
extra metabolites and model 2 _w identified 4 such metabolites. Table 3 presented those overlaps and those extra
metabolites identified by specific multi-TGDR framework.

Statistical language and packages

In order to study the empirical performance of both
multi-TGDR frameworks, we used the real values for
metabolites of the HCC/cirrhosis data (384 metabolites
and 131 samples) but assigned the class membership according to pre-determined logit functions f. Specifically,
the logit functions for class 2 and 3, having class 1 as
reference, were given by following relationship for two
synthesized datasets,
Simulation 1

f 2vs1 ¼ −0:1X 1 −0:8X 2 −0:9X 3 þ 2X 4 þ 1:2X 5 ;
f 3vs1 ¼ 0:4X 1 −0:5X 2 −0:8X 3 þ 1:7X 4 −1:5X 5
where the logits for class 2 and 3 depend only on features X1 ~ X5, but differ in the direction and magnitudes
of the association.
Simulation 2

f 2vs1 ¼ −0:1X 1 þ 2X 4 þ 1:2X 5 ;
f 3vs1 ¼ 1:5X 2 −0:8X 3
where the logits for class 2 and 3 are two function with
different parameters in the second simulation.
By this means, the true relevant features (i.e., X1 X2 X3
X4 X5) are known and performance comparison can be
made between multi-TGDRs and PLS-DA. Here, PLSDA analysis was carried out in the software of SIMCAP + version 12.0 (www.umetrics.com). A feature was
eliminated unless it had VIP values larger than 1 in either of the first two PLS components. The results were
given in Table 1.
In summary, the true relevant features were successfully identified by all methods. The predictive performance of both multi-TGDR frameworks was superior to

Comparison with PLS-DA analysis

The data had also been analyzed using PLS-DA [19].
There, the potential markers were chosen based on the
loading plot of PLS-DA, then evaluated by VIP of the
first two components in PLS-DA and further confirmed
by t-tests. We compared the selected metabolites by the
original analysis with the resulting metabolites from
Multi-TGDR frameworks (using the whole data on which
the original PLS-DA was conducted), there are only 4
overlaps between multi-TGDR global and PLS-DA, and 5
overlaps between multi-TGDR local and PLS-DA, respectively (indicated as * in Table 3).
In order to compare results obtained from PLS-DA and
those from Multi-TGDR, we used the 42 metabolites selected by PLS-DA (as shown on Table 2 in [19]) and
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Table 1 The comparison between Multi-TGDR frameworks and PLS-DA using simulated data
# metabolites

Error on the data (%)

GBS

5-fold CV Error (%)

A. Simulation 1
Multi-TGDR: global No Bagging

105

0.76

0.0100

12.21

Global + Bagging (freq > 30%)

35

10.69

0.0773

12.21

local No Bagging

54 (14, 46)1

2.29

0.0301

14.50

Local + Bagging (freq > 40%)

24 (14, 15)

8.40

0.0539

12.98

89

14.50

0.1313

19.84

PLS-DA + Naïve Bayes as a classifier
B. Simulation 2
Multi-TGDR: global No Bagging

110

0

0.0165

11.45

Global + Bagging (freq > 50%)

21

3.82

0.0237

7.63

106(12, 95)

0

0.0067

9.16

25(9, 18)

3.82

0.0254

8.40

97

6.87

0.1556

16.03

local No Bagging
Local + Bagging (freq > 40%)
PLS-DA + Naïve Bayes as a classifier

A. The performance of multi-TGDR frameworks and PLS-DA on the first simulated data. B. The performance of multi-TGDR and PLS-DA on the second
simulated data.
1
(No.1, No.2): No.1 represents the number of metabolites selected in the first comparison (class 2 versus class 1) by multi-TGDR local. No.2 represents the number
of metabolites selected in the second comparison (class 3 versus class 1).

considered a naïve Bayes model as a classifier to calculate
the posterior probabilities in PLS-DA. The performance
of PLS-DA was shown in Table 2. In summary, the metabolites selected by Multi-TGDR have a better predictive
performance than those by PLS-DA.
Evaluation on the effect of pre-processing filtering

Moderated t-tests using limma [28] were conducted to
identify the differential metabolites between HCC/cirrhosis versus normal to examine the effects of pre-

Figure 2 The schema of the study.

filtering. The cutoff for the false discovery rate (FDR)
was chosen as 0.05. There were 94 down-regulated and
104 up-regulated metabolites in the comparison of cirrhosis to normal, and 63 down-regulated and 186 upregulated metabolites for HCC to normal. In total, 302
unique differentially expressed metabolites were identified by those t-tests. Only 4 metabolites were missing
from the final classifier models (i.e., model 1_w and
2_w). We then reran both multi-TGDRs with those 302
differentially expressed metabolites. The corresponding

Tian et al. BMC Bioinformatics 2014, 15:97
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Figure 3 The comparison between cross validation (CV)-determined tuning parameter k (the iteration number) in both multi-TGDR
frameworks. Global: multi-TGDR global; local: multi-TGDR local.

results were shown in Table 2B and Figure 4. From them,
we can see the performance of both multi-TGDR on the
filtered data decreased but was not substantial. To conclude, pre-filtering may save considerable computational
time with marginal impact on predictive performance.

Conclusions
Metabolites selected by multi-TGDR may provide biological
insight in HCC/cirrhosis. According to the description of

those selected metabolites given by the HMDB, some interesting observations were gained. First, furoic acid is a
metabolite produced by furfural via oxidation. Furfural is
a confirmed animal carcinogen with unknown relevance
to humans, and it has been suggested as a substance that
produces hepatic cirrhosis [29,30]. Here, both multiTGDR versions selected furoic acid, while the coefficients
of both comparisons (i.e., HCC versus normal, cirrhosis
versus normal) are in opposite directions. A significant

Table 2 The predictive performance of Multi-TGDR frameworks and PLS-DA
# metabolites

Error on the data (%)

GBS

5-fold CV Error (%)

A. (without filtering)
Multi-TGDR global No Bagging

45

0

4.24e-05

3.82

Bagging (freq > 40%)

30

0

3.68e-05

3.82

Multi-TGDR local No Bagging

48

0

7.57e-05

5.34

Bagging (freq > 40%)

29

0

5.97e-04

6.11

Multi-TGDR global No Bagging

42

0

1.03e-04

4.58

Bagging (freq > 25%)

37

0

1.13e-04

4.58

Bagging (freq > 40%)

26

0

3.58e-04

4.58

Multi-TGDR local No Bagging

42

0

6.18e-04

6.11

Bagging (freq > 25%)

38

0

6.87e-04

5.34

Bagging (freq > 40%)

25

0

2.24e-03

6.11

42

4.58

4.63e-02

7.63

B. (after moderated t-test filtering)

C. the performance of PLS-DA on the whole data
Naïve Bayes as the extra classifier

A. The performance of multi-TGDR frameworks on the whole data: without moderated t-test filtering. B. The performance of multi-TGDR frameworks on the
reduced data: with t-test filtering and 72 metabolites were filtered out. C. The performance of PLS-DA with naïve Bayes as the classifier. 42 metabolites selected
by original analysis in Zhou’s study ref. [19] were used.
Note: For the reduced data, the optimal cutoff of bagging frequencies is 25%. However, in order to make a fair comparison with the results from the whole data,
we analyzed the reduced data with bagging frequencies as 40% as well.

Tian et al. BMC Bioinformatics 2014, 15:97
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Table 3 The selected metabolites by both multi-TGDR frameworks (the results of model 1_w and model 2_w)
type

mz

RT (min)

β_Cirrhosis

β_HCC

Multi-TGDR global
All

Common

Global

Local

191.04

0.64

0.6521

−0.6011

β_Cirrhosis

β_HCC

Metabolites

Multi-TGDR local
0.7437

−0.4971

Beta-Lactose

240.08

14.79

−0.2734

0.2258

−0.2842

0.0267

1,1′-Ethylidenebistryptophan or 1-aminopyrene

582.24

22.42

−0.4816

0.2596

−0.4854

0.1428

Glutaminyl-Methionine

91.36

8.47

0.1937

−0.9035

0

−0.4716

Unknown

100.32

1.16

0.1965

−0.6931

0

−0.7513

Unknown*

101.32

1.16

0.1209

−0.4617

0

−0.4617

Unknown

139.1

8.65

0.1969

−0.4631

0

−0.4631

Phosphorylcholine

218.08

0.89

0.2614

−0.7598

0

−0.9121

Pregnenolone sulfate

255.96

1.07

0.041

0.2284

0

0.3122

Lsoxanthopterin

256.25

19.08

−0.358

0.9489

0

0.9761

Palmitic amide*

279.08

9.4

0.034

−0.3269

0

−0.4019

Homocarnosine

361.18

19.64

−0.0196

0.0538

0

0.1811

Unknown

540.51

23.17

0.0211

0.2882

0

0.2898

Unknown

599.25

9.78

0.5919

3.8635

0

4.1545

Unknown

239.14

14.47

−0.2198

0.0995

−0.3349

0

Phosphatidic acid

289.21

7.24

−0.1335

−0.0097

−0.1347

0

Neurosporene

356.37

15.91

0.3772

−0.0728

0.2259

0

Unknown

374.38

15.45

0.5133

0.0856

0.2179

0

Unknown

375.39

15.46

1.4191

0.1173

1.3393

0

Cholestanetriol or Unknown

402.42

17.55

0.2209

0.0424

0.4634

0

16(S)-hydroxy-18-oxo-18-CoA-LTE4

585.27

9.09

1.435

−0.1864

1.7132

0

Conjugated bilirubin*

587.27

9.09

0.3402

0.1137

0.2372

0

Conjugated bilirubin*

592.37

6.42

0.3208

−0.0508

0.5229

0

Unknown

633.25

10.31

−0.7011

0.4138

−0.7187

0

Unknown

652.41

4.19

1.2071

0.4634

1.4441

0

Ganglioside GM3 (d18:1/24:0) or Unknown

181.08

8.6

−0.1244

0.0115

0

0

Alpha-Ketooctanoic acid

277.17

10.69

−0.1585

0.1796

0

0

Phosphatidylinositol or Lithocholate 3-O-glucuronide

312.37

18.9

−9.00E-04

−0.0819

0

0

Unknown

315.19

8.7

−0.1527

0.0978

0

0

3-Oxohexadecanoic acid

608.38

3.97

0.1159

0.0187

0

0

Unknown

159

0.62

0

0

−0.158

0.1842

Glycolaldehyde

330.35

15.37

0

0

0.1697

0

Unknown*

634.26

10.31

0

0

−0.0769

0

Indoleacetyl glutamine

810.62

29.87

0

0

0

−0.1817

SM(d18:1/18:0)

The normal controls serve as the reference. All: non-zeros in both comparisons and both versions; Common: selected by both versions, but being zero in one comparison by local; global: selected only by multi-TGDR global version; local: selected only by multi-TGDR local version. Model 1_w: the results of multi-TGDR global
after bagging (BF > 40%); Model2_w: the results of multi-TGDR local after bagging (BF > 40%).
Note: *the overlaps with the metabolites selected by PLS-DA.

decrease of isoxanthopterin has been identified in cancer
patients [31], however, the multi-TGDR results show an
increase instead. It is well known that careful control of
the participants’ intake before a metabolomics experiment
is difficult. With that in mind, many of the HCC subjects
may have received therapeutic treatments that might increase the level of isoxanthopterin, with residual levels

present despite strict diet and intake control during the
metabolomics study. In addition, over-dosage of interventions for cancer patients, especially in a developing country like China is possible. Thus the accumulation of
isoxanthopterin in HCC patients is possible as a result of
long-term over-dosage of relevant drugs. Meanwhile, we
don’t exclude the possibility that HCC has its own unique
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Figure 4 The comparison of the selected metabolites by multi-TGDR frameworks on the whole data and on the reduced data
(BF > 40% for both data). A. Venn-diagram for multi-TGDR global. B. Venn-diagram for multi-TGDR local. The whole data: without moderated
t-test filtering. The reduced data: with t-test filtering and 72 metabolites were filtered out. The metabolites (indexed by m/z values) in red represent
those filtered out by moderated t-tests. The metabolites (indexed by m/z values) in purple represent those selected by multi-TGDR framework on the
whole data analysis, but excluded by bagging.

characteristics in terms of isoxanthopterin and is consequently different from other cancer types. Further investigation on the biological explanation of those selected
metabolites is definitely warranted. Here, our focus is to
present the multi-TGDR frameworks and to demonstrate
their applications in metabolomics.
With the aids of a feature selection algorithm like multiTGDR (an algorithm can provide an explicit predictive
rule and compute the posterior probabilities of the class
membership), it is possible to design a diagnostic kit to
examine the selected metabolites in a clinic setting with
higher sensitivity and specificity. This kit would allow discrimination between HCC developed from HCV/HBV infections apart from cirrhosis with HCV/HBV infections,
which is highly desirable and of scientific importance. One
limitation of our application is that since the proportion
of diseased persons in an observational study may not reflect disease prevalence in the population, care must be
taken in both model construction and evaluation. To

ensure a multi-TGDR model can correctly classify persons
in the general population, one approach is to obtain
weights based on the ratio between the proportion of diseased persons in the population and that in the study. A
comprehensive investigation of these issues is the focus of
our future research.
Two extensions of TGDR are proposed here for multiclass classification problems. By training only one classifier, we specifically address sub-optimality associated with
dividing multi-class classification into individual binary
pairs. The performance of multi-TGDR global has been
shown to be excellent by us previously [4] using simulated
data and two microarray data sets. Compared to multiTGDR global, multi-TGDR local has an almost identical
predictive performance in the HCC metabolomics data
(in both the simulated data and the real data). Additionally, we conducted extra simulations to verify the validity of multi-TGDR local and compared its performance
with multi-TGDR global. The results (included in the

Tian et al. BMC Bioinformatics 2014, 15:97
http://www.biomedcentral.com/1471-2105/15/97

Additional file 1: Supplementary materials) show that
both multi-TGDR algorithms can identify the true relevant
features and discard the irrelevant features. Identical predictive performances are also observed even in cases where
some of features are highly correlated to the relevant features. Intuitively, we hypothesized that multi-TGDR global
should perform better in cases where the classes share
more similarity. This entails that the same set of features is
shared across different classes, but the magnitudes of the
association differ. This may correspond to different stages
of a disease. In contrast, multi-TGDR local may be optimal
in cases where no similarity of the classes is present. This
entails that complete different sets are selected across different classes, which may represent different diseases.
Interestingly, the results from the simulations don’t support this hypothesis. Finally, we also examined whether
multi-TGDR local is associated with less computation time
since it does not need to compute the overall threshold
function fj(v). However, with our current experience on the
simulations and real-world applications, we found the computational effort of these two approaches to be comparable.
This may be due to the fact that compared to the computation of many gradients at each iteration, the computation
of maximum on fcj(v) is negligible. One obvious advantage
of multi-TGDR local is that it may provide us with information on which feature is related to which class/classes.
To conclude, we recommend the use of the multi-TGDR
frameworks for multi-class classifications on “omics” data
because they have excellent predictive capacity. The researchers may choose to run both or either of the multiTGDR frameworks based on their research hypotheses and
data type.
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